Cytokinetics
CYTK
CYTK
192 hedge funds and large institutions have $1.74B invested in Cytokinetics in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 62 increasing their positions, 63 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.22% more ownership
Funds ownership: 103.03% → 105.26% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 63
Holders
192
Holding in Top 10
5
Calls
$5.35M
Puts
$3.23M
Top Buyers
| 1 | +$65.2M | |
| 2 | +$36.1M | |
| 3 | +$16.3M | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$15.6M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$14.7M |
Top Sellers
| 1 | -$101M | |
| 2 | -$18.4M | |
| 3 | -$14M | |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$12.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$11.6M |